日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Asterias rubens Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (cnh), partial CSB-YP846525AQB1
CSB-EP846525AQB1
CSB-BP846525AQB1
CSB-MP846525AQB1
CSB-EP846525AQB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Forkhead box protein O (foxo), partial CSB-YP846526DLU
CSB-EP846526DLU
CSB-BP846526DLU
CSB-MP846526DLU
CSB-EP846526DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Protein CARMIL (carmil), partial CSB-YP846527DKK
CSB-EP846527DKK
CSB-BP846527DKK
CSB-MP846527DKK
CSB-EP846527DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Centruroides sculpturatus Toxin CsE9 CSB-YP846528CGD
CSB-EP846528CGD
CSB-BP846528CGD
CSB-MP846528CGD
CSB-EP846528CGD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Semaphorin-2A (mab-20), partial CSB-YP846529CXY
CSB-EP846529CXY
CSB-BP846529CXY
CSB-MP846529CXY
CSB-EP846529CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable histone-lysine N-methyltransferase set-23 (set-23) CSB-YP846530CXY
CSB-EP846530CXY
CSB-BP846530CXY
CSB-MP846530CXY
CSB-EP846530CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein CLASP-1 (C07H6.3), partial CSB-YP846531CXY
CSB-EP846531CXY
CSB-BP846531CXY
CSB-MP846531CXY
CSB-EP846531CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ciona intestinalis Thioredoxin domain-containing protein 3 homolog (CiIC3), partial CSB-YP846532DTL
CSB-EP846532DTL
CSB-BP846532DTL
CSB-MP846532DTL
CSB-EP846532DTL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Spindle pole body component 97 (spc97), partial CSB-YP846533DKK
CSB-EP846533DKK
CSB-BP846533DKK
CSB-MP846533DKK
CSB-EP846533DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serpentine receptor class beta-1 (srb-1), partial CSB-YP846534CXY1
CSB-EP846534CXY1
CSB-BP846534CXY1
CSB-MP846534CXY1
CSB-EP846534CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhinoceros unicornis NADH-ubiquinone oxidoreductase chain 2 (MT-ND2), partial CSB-YP846535RCQ
CSB-EP846535RCQ
CSB-BP846535RCQ
CSB-MP846535RCQ
CSB-EP846535RCQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhinoceros unicornis NADH-ubiquinone oxidoreductase chain 5 (MT-ND5), partial CSB-YP846536RCQ
CSB-EP846536RCQ
CSB-BP846536RCQ
CSB-MP846536RCQ
CSB-EP846536RCQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Trafficking kinesin-binding protein milt (milt), partial CSB-YP846537DLU
CSB-EP846537DLU
CSB-BP846537DLU
CSB-MP846537DLU
CSB-EP846537DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polypterus ornatipinnis NADH-ubiquinone oxidoreductase chain 1 (MT-ND1), partial CSB-YP846538PKAP
CSB-EP846538PKAP
CSB-BP846538PKAP
CSB-MP846538PKAP
CSB-EP846538PKAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Allene oxide synthase, chloroplastic (CYP74A) CSB-YP846539DOA
CSB-BP846539DOA
CSB-MP846539DOA
CSB-EP846539DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable dehydrin LEA (LEA) CSB-YP846540DOA
CSB-EP846540DOA
CSB-BP846540DOA
CSB-MP846540DOA
CSB-EP846540DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Shaggy-related protein kinase theta (ASK8) CSB-YP846541DOA
CSB-EP846541DOA
CSB-BP846541DOA
CSB-MP846541DOA
CSB-EP846541DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Translationally-controlled tumor protein homolog CSB-YP846542WBS
CSB-EP846542WBS
CSB-BP846542WBS
CSB-MP846542WBS
CSB-EP846542WBS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spodoptera frugiperda 40S ribosomal protein S28 (RpS28) CSB-YP846543FKQ
CSB-EP846543FKQ
CSB-BP846543FKQ
CSB-MP846543FKQ
CSB-EP846543FKQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spodoptera frugiperda 40S ribosomal protein S13 (RpS13) CSB-YP846544FKQ
CSB-EP846544FKQ
CSB-BP846544FKQ
CSB-MP846544FKQ
CSB-EP846544FKQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×